Skip to main content
Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis

Fig. 4

Autoantibody isotype-related mean titer change of responders (RRs) and non-responders (NRRs) upon RTX -treatment. Mean titer course of IgM and especially IgA antibodies against MCV (AMCV) were significantly different in RRs and NRRs to RTX, with higher reductions in RRs after six months. Changes in RF isotypes and antibodies against CCP (ACCP) showed no significant difference between groups

Back to article page